The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice
Accreditation: 8.42 ABIM MOC II | 8.42 AMA PRA Category 1 Credit™ | 8.42 ACPE Pharmacy
Venue: Hyatt Regency Boston, One Avenue de Lafayette, Boston, MA, United States
Official conference page for The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice . https://binaytara.org/projects/conferences/the-international-gynecologic-oncology-consensus-conference-marrying-evidence-to-practice-1
About The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Day 1: Friday, November 6th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Anuja Jhingran, MD
01:20 PM - 01:30 PM
Molecular staging of endometrial cancer: approach to p53 abnormal tumors – Carol Aghajanian, MD
01:30 PM - 01:40 PM
A critical review of the role of radiation in early-stage endometrial cancer – Ann Hoge Klopp, MD
01:40 PM - 02:10 PM
Discussion
Moderators:
Anuja Jhingran, MD
Panelists:
Carol Aghajanian, MD; Ann Hoge Klopp, MD
02:10 PM - 02:25 PM
Vote (audience participation, panel vote)
Session Chair: Stephanie Lherueux, MD
02:40 PM - 02:50 PM
Adjuvant PARP inhibitors: Update on long-term benefit – Robert Coleman, MD
02:50 PM - 03:00 PM
Is there a role for PARPi after progression on a prior PARPi? – Joyce Liu, MD
03:00 PM - 03:30 PM
Discussion
Moderators:
Stephanie Lherueux, MD
Panelists:
Robert Coleman, MD; Joyce Liu, MD
03:30 PM - 03:45 PM
Vote (audience participation, panel vote)
Session Chair: Linda Duska, MD
04:00 PM - 04:10 PM
The current state of FOLR1 directed treatments: mirvetuximab and beyond – Kathleen Moore, MD
04:10 PM - 04:20 PM
B96 Trial – Nicoletta Colombo, MD
04:20 PM - 04:30 PM
Rosella – Alexander B Olawaiye, MD
04:30 PM - 05:00 PM
Discussion
Moderators:
Linda Duska, MD
Panelists:
Kathleen Moore, MD; Nicoletta Colombo, MD; Alexander B Olawaiye, MD; Debra Richardson, MD, Other
05:00 PM - 05:15 PM
Vote (audience participation, panel vote)
Day 2: Saturday, November 7th, 2026
Session Chair: Dmitriy Zamarin, MD
08:30 AM - 08:40 AM
The role of ADCs in endometrial cancer – Noelle Cloven, MD
08:40 AM - 08:50 AM
Targeting HER2: is earlier better? – Amanda Nickles Fader, MD
08:50 AM - 09:20 AM
Discussion
Moderators:
Dmitriy Zamarin, MD
Panelists:
Noelle Cloven, MD; Amanda Nickles Fader, MD
09:20 AM - 09:35 AM
Vote (audience participation, panel vote)
